Default company panoramic image

Genetic Microdevices

We have developed a vastly disruptive technology that analyses proteins and DNA with ultra-high performance, addressing a $10bn market.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Richmond, GB-ENG, United Kingdom
  • Currency USD
  • Founded January 2006
  • Employees 5
  • Website

Company Summary

Pharamaceutical companies face a tremendeus challenge to invest in new drugs, when the efficiency of R&D is very poor. There is a dire need for new generation analytical technologies that increase the efficiency of drug development. GMD addresses these needs by providing an ultra-potent, cost-effective technology based on a disposable plastic chip. Our customers are pharmaceutical and diagnostic companies, health care and research institututions.


  • Default avatar
    Dimitrios Sideris

    Dimitrios Sideris is the Inventor & CEO. Dimitrios has 12 years experience in commercializing
    cutting edge technology. He has a PhD in particle physics from Imperial College.

    Career highlights:
    • 2000: Head of Technology for an Imperial College London Spinout, DeltaDot, who currently
    have products in the market. Award for Most Innovative and Data Intensive Technology in
    the Supercomputing conference in Baltimore.
    • 2005-date: Raised $2M

  • Default avatar
    Alan Edwards

    Alan was C.E.O of Credent Vascular Technologies Ltd., formed after a successful £10 million Management Buy-Out from Cardiotech International Inc. Credent was sold in 2004. He is Chairman of Asep Healthcare Ltd., a profitable Imperial College spin-out company; Chairman, of Dialog Devices Ltd; a University of Loughborough Spin-out and an advisor to Ferlin Medical Ltd., Scubacraft and Digital Art.

  • Default avatar
    Andreas Manz
    Scientific Board

    Andreas Manz is one of the pioneers in microchip technology used for chemical applications. He was involved in the development of high speed analyzers based on capillary electrophoresis, liquid chromatography and flow injection analysis. These analyzers are based on the microfabrication know-how originally developed for microelectronics. He conducted most of his early research with his group at Ciba-Geigy Ltd. in Basel, Switzerland, then at Imper


  • Default avatar
    Clark Holt
    Default avatar
    Farringdon & Co

Previous Investors

  • Default avatar
    Vasilis Exarchou, Barry May, Andrew May, Giorgos Kyritsis, Mishaal Almashan, Konstantina Panagiotou